recent publications

• academic article

  • Zhou, Z. M., Wang, K., Penn, M. S., Marso, S. P., Lauer, M. A., Forudi, F., Zhou, X. R., Qu, W., Lu, Y., Stern, D. M., Schmidt, A. M., Lincoff, A. M., et al. Receptor for age (rage) mediates neointimal formation in response to arterial injury Circulation  2003 107:2238-2243  DOI:10.1161/01.cir.0000063577.32819.23  PMID:12719284
  • Cho, L., Bhatt, D. L., Marso, S. P., Brennan, D., Holmes, D. R., Califf, R. M., Topol, E. J. An invasive strategy is associated with decreased mortality in patients with unstable angina and non-st-elevation myocardial infarction: Gusto iib trial American Journal of Medicine  2003 114:106-111  DOI:10.1016/s0002-9343(02)01446-8  PMID:12586229
  • Bhatt, D. L., Marso, S. P., Hirsch, A. T., Ringleb, P. A., Hacke, W., Topol, E. J. Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus American Journal of Cardiology  2002 90:625-8  DOI:10.1016/s0002-9149(02)02567-5  PMID:12231089
  • Labinaz, M., Kilaru, R., Pieper, K., Marso, S. P., Kitt, M. M., Simoons, M. L., Califf, R. M., Topol, E. J., Armstrong, P. W., Harrington, R. A., Investigators, Pursuit Outcomes of patients with acute coronary syndromes and prior coronary artery bypass grafting - results from the platelet glycoprotein iib/iiia in unstable angina: Receptor suppression using integrilin therapy (pursuit) trial Circulation  2002 105:322-327  DOI:10.1161/hc0302.102578  PMID:11804987
  • Park, S. H., Marso, S. P., Zhou, Z. M., Foroudi, F., Topol, E. J., Lincoff, A. M. Neointimal hyperplasia after arterial injury is increased in a rat model of non-insulin-dependent diabetes mellitus Circulation  2001 104:815-819  DOI:10.1161/hc3301.092789  PMID:11502708
  • Marso, S. P., Bhatt, D. L., Roe, M. T., Houghtaling, P. L., Labinaz, M., Kleiman, N. S., Dyke, C., Simmoons, M. L., Califf, R. M., Harrington, R. A., Topol, E. J., Investigators, Pursuit Enhanced efficacy of eptifibatide administration in patients with acute coronary syndrome requiring in-hospital coronary artery bypass grafting Circulation  2000 102:2952-2958  PMID:11113045
  • Cho, L., Marso, S. P., Bhatt, D. L., Topol, E. J. Optimizing percutaneous coronary revascularization in diabetic women: Analysis from the epistent trial Journal of Womens Health & Gender-Based Medicine  2000 9:741-746  DOI:10.1089/15246090050147718  PMID:11025866
  • Marso, S. P., Ellis, S. G., Gurm, H. S., Lytle, B. W., Topol, E. J. Proteinuria is a key determinant of death in patients with diabetes after isolated coronary artery bypass grafting American Heart Journal  2000 139:939-944  DOI:10.1067/mhj.2000.105699  PMID:10827372
  • Bhatt, D. L., Marso, S. P., Lincoff, A. M., Wolski, K. E., Ellis, S. G., Topol, E. J. Abciximab reduces mortality in diabetics following percutaneous coronary intervention Journal of the American College of Cardiology  2000 35:922-928  DOI:10.1016/s0735-1097(99)00650-6  PMID:10732889
  • Marso, S. P., Lincoff, A. M., Ellis, S. G., Bhatt, D. L., Tanguay, J. F., Kleiman, N. S., Hammoud, T., Booth, J. E., Sapp, S. K., Topol, E. J., Investigators, Epistent Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus - results of the epistent (evaluation of platelet iib/iiia inhibitor for stenting trial) diabetic substudy Circulation  1999 100:2477-2484  PMID:10604884
  • Marso, S. P., Ellis, S. G., Tuzcu, E. M., Whitlow, P. L., Franco, I., Raymond, R. E., Topol, E. J. The importance of proteinuria as a determinant of mortality following percutaneous coronary revascularization in diabetics Journal of the American College of Cardiology  1999 33:1269-1277  DOI:10.1016/s0735-1097(99)00035-2  PMID:10193727